Purchase Order 75N91018P00469

Award Date 8/1/18
Potential Completion Date 7/31/20
Potential Value $221K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oakland, CA 94612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm fixed-price purchase order to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, a non-profit healthcare provider, to conduct research on "KAISER RISK OF NEW MALIGNANCIES FOLLOWING BREAST CANCER." The contract has a potential value of $149,990.00 and a period of performance ending on August 31, 2018. No...
This federal contract award to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, is for a Firm Fixed Price Purchase Order from the Department of Health and Human Services National Institutes of Health National Cancer Institute. The contract, valued at $249,998.00, is for a project titled "BREAST CANCER SURVIVORS COHORT LATE EFFECTS OF BREAST CANCER TREATMENTS" with a completion date of March 31, 2022. The contract has no set-aside designation. Kaiser Foundation...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $149,993 firm fixed-price purchase order to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract is for the retrieval and tracking of breast tissue sample blocks to support studies of the risk of new malignancies following breast cancer. This contract is not set aside for any specific business category. Kaiser...
This firm-fixed-price purchase order, valued at $249,999.00, was awarded by the National Cancer Institute (NCI) to the Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract provides for Kaiser Permanente to access electronic health data files from their Hawaii operations to assemble a cohort of female breast cancer survivors for epidemiological research. This contract supports the NCI's Radiation Epidemiology Branch and...
This federal contract award, valued at $149,884.00, was issued by the National Cancer Institute (NCI) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for data collection services related to treatment-related second cancers after breast cancer. The contract has a 1-year period of performance and does not have a set-aside designation. Kaiser Permanente is a large, non-profit healthcare provider and research organization that frequently partners with federal agencies like the...
This federal contract award is for $636,976.25 and was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a nonprofit healthcare provider and research organization. The contract is for infrastructure setup and is a delivery order under the larger "Cancer Study Cohort Recruitment" indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The...
This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for a study on treatment-related second cancers after breast cancer. The contract, valued at $149,828.00, expands the scope and follow-up of an existing Kaiser Permanente Washington breast cancer survivors' cohort into the National Cancer Institute's Breast Cancer...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Kaiser Foundation Hospitals, doing business as Kaiser Permanente. The $22,230.31 contract is for data queries and analysis related to outcomes after breast cancer. The award is not associated with a set-aside program. Kaiser Permanente, as a large integrated healthcare system and research organization, has a significant...
This federal contract award is for $15,000.00 and was issued by the National Cancer Institute (NCI) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for data services. The contract has an ultimate completion date of September 22, 2025 and is a firm fixed-price purchase order. Kaiser Foundation Hospitals is a prominent non-profit healthcare provider and research organization that has extensive expertise in medical research, clinical studies, and public health initiatives....
The federal contract award, with ID 75N91018D00021|75N91020F00051, was issued by the National Cancer Institute, a civilian agency, to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. This $844,110.24 delivery order award is part of a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle titled "Cancer Study Cohort Recruitment." The contract is for continued infrastructure setup and does not have a...

This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The $220,562.00 firm fixed-price purchase order is for treatment-related research on second cancers following breast cancer, with a period of performance from August 1, 2018 to July 31, 2020. This award is not associated with a set-aside program. Kaiser Permanente has extensive experience providing research services and solutions to federal agencies like HHS, the Centers for Disease Control and Prevention, and the Food and Drug Administration through both contracts and grants, covering areas such as vaccine safety, disease surveillance, clinical trials, and health information systems.

Generated 3/22/24, 4:32 PM